Robert H. Vonderheide

4 ta ish

University of Pennsylvania

1. Understanding the tumor immune microenvironment (TIME) for effective therapy

   Mikhail Binnewies, Edward W. Roberts, Kelly Kersten +15

   Sharh maqolaOAOchiq kirish20186 iqtibos

   ABIABI:AkademIndex/2026.other.236556

2. CD40 Agonist Antibodies in Cancer Immunotherapy

   Robert H. Vonderheide

   Sharh maqola20193 iqtibos

   ABIABI:AkademIndex/2026.other.714878

3. CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans

   Gregory L. Beatty, E. Gabriela Chiorean, Matthew P. Fishman +10

   MaqolaOAOchiq kirish20112 iqtibos

   ABIABI:AkademIndex/2026.other.207739

4. The Immune Revolution: A Case for Priming, Not Checkpoint

   Robert H. Vonderheide

   Sharh maqolaOAOchiq kirish20182 iqtibos

   ABIABI:AkademIndex/2026.other.207784